Quantitative ultrasound can assess the regeneration process of tissue-engineered cartilage using a complex between adherent bone marrow cells and a three-dimensional scaffold by Hattori, Koji et al.
Open Access
Available online http://arthritis-research.com/content/7/3/R552
R552
Vol 7 No 3 Research article
Quantitative ultrasound can assess the regeneration process of 
tissue-engineered cartilage using a complex between adherent 
bone marrow cells and a three-dimensional scaffold
Koji Hattori1, Yoshinori Takakura1, Hajime Ohgushi2, Takashi Habata1, Kota Uematsu1, 
Jun Yamauchi1, Kenji Yamashita3, Takashi Fukuchi3, Masao Sato3 and Ken Ikeuchi4
1Department of Orthopaedic Surgery, Nara Medical University, Nara, Japan
2National Institute of Advanced Industrial Science and Technology, Amagasaki Site, Hyogo, Japan
3Life Science Laboratories, Life Science RD Center, Kaneka Corporation, Takasago, Hyogo, Japan
4Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
Corresponding author: Koji Hattori, hattori@naramed-u.ac.jp
Received: 10 Jan 2005 Revisions requested: 25 Jan 2005 Revisions received: 1 Feb 2005 Accepted: 8 Feb 2005 Published: 1 Mar 2005
Arthritis Research & Therapy 2005, 7:R552-R559 (DOI 10.1186/ar1710)
This article is online at: http://arthritis-research.com/content/7/3/R552
© 2005 Hattori et al.; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/
2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Articular cartilage (hyaline cartilage) defects resulting from
traumatic injury or degenerative joint disease do not repair
themselves spontaneously. Therefore, such defects may require
novel regenerative strategies to restore biologically and
biomechanically functional tissue. Recently, tissue engineering
using a complex of cells and scaffold has emerged as a new
approach for repairing cartilage defects and restoring cartilage
function. With the advent of this new technology, accurate
methods for evaluating articular cartilage have become
important. In particular, in vivo evaluation is essential for
determining the best treatment. However, without a biopsy,
which causes damage, articular cartilage cannot be accurately
evaluated in a clinical context. We have developed a novel
system for evaluating articular cartilage, in which the acoustic
properties of the cartilage are measured by introducing an
ultrasonic probe during arthroscopy of the knee joint. The
purpose of the current study was to determine the efficacy of
this ultrasound system for evaluating tissue-engineered cartilage
in an experimental model involving implantation of a cell/scaffold
complex into rabbit knee joint defects. Ultrasonic echoes from
the articular cartilage were converted into a wavelet map by
wavelet transformation. On the wavelet map, the percentage
maximum magnitude (the maximum magnitude of the
measurement area of the operated knee divided by that of the
intact cartilage of the opposite, nonoperated knee; %MM) was
used as a quantitative index of cartilage regeneration. Using this
index, the tissue-engineered cartilage was examined to
elucidate the relations between ultrasonic analysis and
biochemical and histological analyses. The %MM increased
over the time course of the implant and all the hyaline-like
cartilage samples from the histological findings had a high
%MM. Correlations were observed between the %MM and the
semiquantitative histologic grading scale scores from the
histological findings. In the biochemical findings, the chondroitin
sulfate content increased over the time course of the implant,
whereas the hydroxyproline content remained constant. The
chondroitin sulfate content showed a similarity to the results of
the %MM values. Ultrasonic measurements were found to
predict the regeneration process of the tissue-engineered
cartilage as a minimally invasive method. Therefore, ultrasonic
evaluation using a wavelet map can support the evaluation of
tissue-engineered cartilage using cell/scaffold complexes.
Introduction
Defects in articular cartilage (hyaline cartilage) resulting from
traumatic injury or degenerative joint disease do not repair
themselves spontaneously, because of the low mitotic activity
of chondrocytes and the avascular nature of this type of carti-
lage [1,2]. Therefore, defects may require novel regenerative
strategies to restore the biological and biomechanical function
of the tissue. Recently, tissue engineering using cell/scaffold
complexes has emerged as an approach for repairing cartilage
defects and restoring cartilage function [3-5]. However, little is
known about which scaffolds and which cells (chondrocytes
or cells derived from bone marrow) are effective for the
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treatment of cartilage defects. Furthermore, the length of time
required for chondrocyte maturation or stem cell differentiation
into hyaline cartilage is unknown.
With the advent of new technologies in scaffold processing
and cell biology, accurate methods for evaluating articular car-
tilage have become important. In particular, in vivo evaluation
is essential for determining the best treatment. However, with-
out a biopsy, which causes damage, articular cartilage cannot
be accurately evaluated in a clinical context.
We therefore developed a new ultrasonic evaluation system
for articular cartilage and showed that this system can quanti-
tatively evaluate cartilage degeneration clinically [6,7]. The
analysis system is based on wavelet transformation of the
reflex echogram from articular cartilage. Our previous study
revealed that the system could predict the histological findings
for tissue-engineered cartilage [8,9]. However, it remained to
be seen whether this system could accurately evaluate tissue-
engineered cartilage from cell/scaffold complexes, especially
the regeneration process. The purpose of the present study
was to find out. Therefore, we fabricated three-dimensional
scaffolds using a biodegradable polymer to engineer hyaline-
cartilage-like tissue derived from adherent bone marrow cells
and evaluated the tissue-engineered cartilage after implanta-
tion in rabbit cartilage defects. We investigated whether ultra-
sound could evaluate the regeneration process at 4 and 12
weeks after the implantation of a cell/scaffold complex. The
relations between the ultrasonic examination and histological
or biochemical examinations were analyzed.
Materials and methods
Three-dimensional PLGA scaffold
The biodegradable scaffolds (GC Corporation, Tokyo, Japan)
used in this study were described previously [10-12]. The
scaffolds (5 mm in diameter, 1.5 mm thick) were composed of
poly(lactic-glycolic acid) (PLGA) with a molecular mass of
approximately 100,000. The outline of the scaffold construc-
tion is described below. Poly(DL-lactic-co-glycolic acid) was
dissolved in dioxane added to sodium citrate particles and
then frozen. The PLGA scaffold was created by a series of
processes involving evaporating the solvent, washing with
water to remove salts, and drying the frozen PLGA/sodium cit-
rate. The pores at the top of the scaffold were created by the
salt leaching and those at the bottom were made by the sol-
vent evaporation. Therefore, the scaffold had micropores on
the top surface and had numerous cylindrical boreholes (Fig.
1), and within the scaffold the cells lay in a uniform array at the
palisade. The average pore size in the unit area on the top sur-
face of the scaffold was 300µm. Since the micropores were
present only on the top surface, the cultured cells infiltrated
the scaffold after instillation of the cell suspension and did not
leak out.
Figure 1
The three-dimensional poly(lactic-glycolic acid) (3D-PLGA) scaffold The three-dimensional poly(lactic-glycolic acid) (3D-PLGA) scaffold. The micropore side (cell seeding side) (a) and a cross section (b) of the scaf-
fold. Schematic illustration of cell seeding (left) and scanning electron photomicrograph of cross section of cells seeded in the 3D-PLGA scaffold 
(right) (c). The cells lie in a uniform array at the palisades, similar to hyaline cartilage. Gross appearance of a cartilage defect in the patella groove 
implanted with a complex between adherent bone marrow cells and 3D-PLGA scaffold (d). The arrows indicate cell/PLGA scaffold.Available online http://arthritis-research.com/content/7/3/R552
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Culture of adherent bone marrow cells
Twenty adult male Japanese white rabbits (3 to 4 kg) were
used in this study; they were individually maintained in
stainless-steel cages. The rabbits were anesthetized with a
mixture of ketamine (50 mg/ml) and xylazine (20 mg/ml) at a
ratio of 2:1, via a dose of 1 ml/kg injected intramuscularly into
the gluteal muscle. Bone marrow was then isolated from the
humeral head using an 18-gauge bone marrow needle, and 5
ml of the marrow was drawn into a 10-ml syringe containing
0.1 ml heparin (3,000 U/ml). The released cells were trans-
ferred to a T-75 flask (Costar, Cambridge, MA, USA) contain-
ing 15 ml of medium. The medium used was Eagle's minimal
essential medium (MEM) containing 10% fetal bovine serum
and antibiotics (penicillin, 100 U/ml; streptomycin, 0.1 mg/ml;
and amphotericin B (Fungizone), 0.25 g/ml; all from Sigma
Chemicals, St Louis, MO, USA). The cells were grown in a
humidified atmosphere of 5% carbon dioxide at 37°C and the
medium was replaced with fresh medium every 2 days. No
growth factors were added. The cell culture was maintained
for 2 weeks until the cells reached confluence, and then the
cultured adherent bone marrow cells were released from the
substratum using 0.25% trypsin and counted in a hemocytom-
eter. The cultured cells obtained from each rabbit were
reseeded onto three-dimensional PLGA scaffolds by simply
dropping the cell suspension onto the scaffolds. The density
of the cultured cells in a scaffold was 1 × 107 cells/cm3. To
these composites in 35-mm tissue-culture plates we added 2
ml of fresh medium for subculture and the cultures were left to
stand overnight at 37°C in 5% carbon dioxide atmosphere.
During this static overnight culture, the cultured cells in the
scaffold lay in uniform arrays in the palisades. The next day, the
composites of adherent bone marrow cells with the three-
dimensional PLGA scaffold were implanted into osteochon-
dral defects in rabbit knee joints.
Implantation
Under general anesthesia as described above, an anterome-
dial arthrotomy was performed in one knee with the joint flexed
maximally. The patella was dislocated laterally and the surface
of the femoropatellar groove was exposed. A full-thickness
cylindrical cartilage defect (5 mm in diameter, 1.5 mm deep)
was created in the patellar groove of the knee using a chisel
and a disposable stainless-steel punch. After washing the
knee with saline solution and drying with a swab to remove any
debris, in some rabbits the defect in one knee was covered
with a cell/PLGA scaffold, with the surface bearing the micro-
pores facing the subchondral bone; this was the tissue-engi-
neered-cartilage group (group T; n = 14). In a control group
(group C; n = 6), defects were washed with saline solution
and dried in the same way but were left without any further
treatment. Finally, fibrin sealant (Tisseel®; Baxter AG, Vienna,
Austria) was applied between the scaffold and the edge of the
defect in group T and to the edge of the defect in group C. The
wound was then closed in layers with 2-0 vicryl sutures.
The rabbits were returned to their cages and allowed to move
freely without joint immobilization. The rabbits were humanely
killed with an overdose of phenobarbital sodium salt at 4 and
12 weeks in group T (groups T-4 (n = 8) and T-12 (n = 6),
respectively) and at 12 weeks in group C (n = 6). All the knee
joints were opened and the cartilage surfaces were observed
with the naked eye and photographed. The knee joint was dis-
sected free from all the soft tissues and the tibia was removed.
The distal femur was cut proximal to the patellofemoral joint
and cartilage samples were taken. All the animals were oper-
ated on in accordance with the guidelines for animal experi-
ments of the Nara Medical University Ethics Committee.
Ultrasound measurements
The ultrasonic evaluation method has been described previ-
ously (Fig. 2) [6,7,13]. Briefly, the examination was carried out
in saline solution, using a transducer and pulser receiver (Pan-
ametrics Japan, Tokyo, Japan). The transducer (3 mm in diam-
eter, 3 mm long) sent and received a flat ultrasonic wave of 10
MHz center frequency. The reflex echogram from the cartilage
was transformed into a wavelet map using wavelet transforma-
tion. The wavelet transformation (W(a,b)) of the reflex echo-
gram (f(t)) is expressed by:
where Ψ(t) is the mother wavelet function.
For the mother wavelet function, Gabor's function was
selected. As a quantitative index of the wavelet map, the max-
imum magnitude was selected. This index was calculated
automatically with a personal computer. The results obtained
for the ultrasonic evaluation were the averages of five meas-
urements. For the cartilage defect area, the measurement
points were the center and four points at 1 mm above, below,
left, and right of the center. The percentage maximum magni-
tude (the maximum magnitude of the measurement area of the
operated knee divided by that of the intact cartilage of the
opposite, nonoperated knee; %MM) was used as a quantita-
tive index of the cartilage regeneration.
Histological analysis
After ultrasonic evaluation, each cartilage sample was divided
in two along a sagittal plane using a diamond band saw
(EXAKT BS300CL; Meiwa, Tokyo, Japan). One part was used
for histological analysis and the other for biochemical analysis.
Histological samples were fixed in 10% formalin, decalcified in
EDTA, and embedded in paraffin. Sagittal sections (5 µm
thick) were prepared from the center of the defect area and
stained with hematoxylin and eosin, alcian blue, and safranin-
O–fast green. Sections stained with safranin-O–fast green
were scored by an orthopedic surgeon under blinded
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conditions according to the semiquantitative histologic grad-
ing scale composed of six categories described by Caplan
and colleagues [14] and were assigned a score ranging from
0 to 16 points. A high total score represented good cartilage
regeneration.
Biochemical analysis
The chondroitin 4-sulfate, chondroitin 6-sulfate, and dermatan
sulfate contents were evaluated to quantify the proteoglycan
content using high-performance liquid chromatography analy-
sis [15]. The hydroxyproline content was evaluated to quantify
the collagen content [16].
Statistic analysis
All data in this study are reported as means ± standard devia-
tions. Differences were analyzed using the nonparametric
Mann–Whitney U test. Pearson correlations were performed
to determine the associations between the ultrasonic data and
the histological data. The significance level was set at P <
0.05.
Results
Ultrasonic analysis
The %MM values were 29.8 ± 15.1% in group C, 38.8 ±
16.9% in group T-4, and 76.5 ± 18.7% in group T-12 (Fig. 3).
Significant differences in the %MM were seen between C and
T-12 (P = 0.007) and between T-4 and T-12 (P = 0.007). The
average %MM in group T-4 was higher than that in group C,
but the difference was not significant (P = 0.32).
Histological findings
In the histological findings, the defect area in group C was
filled with fibrous tissue. None of the defects from group C
contained any fibrocartilage or hyaline-like cartilage (Fig. 4a).
The defect area in group T-4 was filled with scattered
Figure 2
Schematic illustration of articular cartilage analysis and measurement methods of cartilage samples used in [13] Schematic illustration of articular cartilage analysis and measurement methods of cartilage samples used in [13]. A reflex echo of articular cartilage 
(upper) and a wavelet map (lower) are shown on the right. The maximum magnitude is indicated by the gray scale and the percentage maximum 
magnitude (the maximum magnitude of the measurement area divided by that of the intact cartilage of the nonoperated knee; %MM) is used as a 
quantitative index of cartilage regeneration.
Figure 3
Bar graph representing ultrasonic findings in rabbits with cartilage  defects treated with cell/scaffold implants Bar graph representing ultrasonic findings in rabbits with cartilage 
defects treated with cell/scaffold implants. Group C, control defect 
group; Group T-4, tissue-engineered-cartilage group at 4 weeks after 
implantation; Group T-12, tissue-engineered-cartilage group at 12 
weeks after implantation. The error bars represent the standard devia-
tion of each group. The percentage maximum magnitude is expressed 
as the maximum magnitude of the measurement area in the operated 
knee, divided by that of the intact cartilage of the opposite, nonop-
erated knee. *P < 0.05 on the nonparametric Mann–Whitney U test.Available online http://arthritis-research.com/content/7/3/R552
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cartilage-like tissue in the scaffold. Chondroid cells with round
nuclei were observed in an extracellular matrix showing normal
or nearly normal safranin-O staining (Fig. 4b). The defect area
in group T-12 was filled with hyaline-like cartilage, and chon-
droid cells lay in a uniform array in the palisades (Fig. 4c). The
semiquantitative histologic grading scale scores were 4.17 ±
1.72 for group C, 4.88 ± 1.81 for group T-4, and 10.7 ± 0.82
for group T-12 (Fig. 5). Significant differences in the scores
were found between C and T-12 (P = 0.004), and between T-
4 and T-12 (P = 0.003). There was a correlation between the
%MM from the ultrasonic examinations and the semiquantita-
tive histologic grading scale scores for the overall results of all
the measurements (R2 = 0.66) (Fig. 6). The histological scor-
ing showed a strong similarity to the results of the %MM
values.
Figure 4
Photomicrographs of cartilage defect lesions in rabbits Photomicrographs of cartilage defect lesions in rabbits. (a) Group with control (untreated) defects (group C); and groups given tissue-engineered 
cartilage implants at (b) 4 weeks after implantation (group T-4) and (c) 12 weeks after implantation (group T-12). Safranin-O–fast-green staining; 
original magnification × 2.5.
Figure 5
Bar graph representing semiquantitative histologic gradings for the  three groups of rabbits with cartilage defects Bar graph representing semiquantitative histologic gradings for the 
three groups of rabbits with cartilage defects. Group with control 
(untreated) defects (group C); and groups given tissue-engineered car-
tilage implants at 4 weeks after implantation (group T-4) and 12 weeks 
after implantation (group T-12). Error bars represent standard devia-
tions. *P < 0.05 on the nonparametric Mann–Whitney U test.
Figure 6
Scatter plot of ultrasound findings in rabbits with cartilage defects  treated with cell/scaffold implants Scatter plot of ultrasound findings in rabbits with cartilage defects 
treated with cell/scaffold implants. The percentage maximum magni-
tude is expressed as the maximum magnitude of the measurement area 
in the operated knee, divided by that of the intact cartilage of the oppo-
site, nonoperated knee.Arthritis Research & Therapy    Vol 7 No 3    Hattori et al.
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Biochemical analyses
The mean chondroitin sulfate contents were 22.9 nmol/mg in
group C, 59.9 nmol/mg in group T-4, and 112.1 nmol/mg in
group T-12 (Fig. 7). Significant differences in the chondroitin
sulfate contents were found between group T-12 and group C
(P = 0.006). The mean hydroxyproline contents were 28.5 µg/
mg in group C, 25.0 µg/mg in group T-4, and 26.6 µg/mg in
group T-12. There were no significant differences among the
three groups. In the biochemical findings, the chondroitin
sulfate content showed a similarity to the results of the %MM
values.
Discussion
In this study, ultrasonic measurements were found to predict
the process of cartilage regeneration using tissue-engineered
cartilage as a minimally invasive method. The main finding of
the study is that the ultrasonic results were able to judge car-
tilage regeneration on the basis of objective data such as the
%MM, since all the hyaline-like cartilage had a high %MM and
the %MM increased with increasing cartilage regeneration.
Therefore, ultrasound could be used to examine the micro-
structure of tissue-engineered cartilage using cell/scaffold
complexes and investigate the length of time required for stem
cells in a scaffold to differentiate into hyaline cartilage without
a biopsy.
A three-dimensional porous scaffold is thought to be neces-
sary for cartilage tissue engineering, in order to prevent the
seeded cells from diffusing out of the defect site and to pro-
vide the cells with an optimal environment for cartilage differ-
entiation [17-20]. Almost all of the scaffolds investigated have
been fabricated using biodegradable polymers that have
received approval for use from the US Food and Drug Admin-
istration. These polymers are favorable for the synthesis and
secretion of a cartilaginous matrix, such as proteoglycans and
type II collagen, and act as a physical and mechanical support
for the seeded cells and their developing matrix until the poly-
mer is remodeled by the host tissue [21]. Therefore, the clini-
cal application of cell/scaffold complexes for cartilage
regeneration is anticipated.
There are numerous clinical methods of grading regenerated
cartilage at the time of surgery or arthroscopy by direct obser-
vation of the cartilage surface [22-24]. However, accurate
evaluation of cartilage regeneration from cell/scaffold com-
plexes is difficult by macroscopic observation alone. In addi-
tion, it is well established that probing cannot evaluate the
cartilage condition quantitatively. As a quantitative method that
could replace probing, attempts have been made to evaluate
cartilage using MRI, but such in situ evaluation has been per-
formed only in experimental trials [25-27]. Cartilage biopsy
and histological examination have been performed to evaluate
articular cartilage clinically. However, the histological score is
defined by the subjectivity of the examiner, and it is still difficult
to measure the degree of cartilage regeneration nondestruc-
tively. Therefore, ultrasonic evaluation using a wavelet map will
be useful for supporting the evaluation of tissue-engineered
cartilage using cell/scaffold complexes.
Recently, high-frequency ultrasonography was used to assess
cartilage degeneration quantitatively. Chérin and colleagues
[28] revealed a relation between quantitative ultrasound and
maturation-related changes in rat cartilage. Jaffré and
colleagues [29] reported that quantitative 55 MHz ultrasound
allowed detection of early cartilage lesions due to experimen-
tal arthritis and could also detect the effects of anti-inflamma-
tory drugs. Therefore, high-frequency ultrasonography could
be useful for investigating structural changes in the cartilage
matrix and evaluating the efficacy of specific therapeutic
agents. However, no studies have focused on assessing
Figure 7
Bar graphs representing cartilage constituents in rabbits with cartilage defects given cell/scaffold implants Bar graphs representing cartilage constituents in rabbits with cartilage defects given cell/scaffold implants. Group with control (untreated) defects 
(group C); and groups given tissue-engineered cartilage implants at 4 weeks after implantation (group T-4) and 12 weeks after implantation (group 
T-12). Error bars represent standard deviations. *P < 0.05 on the nonparametric Mann–Whitney U test.Available online http://arthritis-research.com/content/7/3/R552
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tissue-engineered cartilage using high-frequency ultrasonog-
raphy. In our previous work, we found that ultrasound
assessment using wavelet transformation could predict the
histological findings of tissue-engineered cartilage [8,9].
Using the same method, Kuroki and colleagues successfully
assessed the cartilage condition of osteochondral plugs when
articular cartilage defects were treated with an autologous
osteochondral graft [30]. Moreover, this method has been
used to assess living human cartilage under arthroscopy [7].
Therefore, ultrasound assessment using wavelet transforma-
tion should contribute to novel therapies for cartilage
regeneration.
Although, the %MM was used as a quantitative index of the
regenerated cartilage, what the %MM is closely related to
remains unknown. Töyräs and colleagues [31] reported that
ultrasound reflection could detect structural changes in the
superficial collagen network and that tangential collagen fibrils
act as ultrasound reflectors at the cartilage surface. Pellaumail
and colleagues [32] stated that changes in high-frequency
ultrasound back scatter were related to changes in the extra-
cellular matrix collagen and most likely in its fibrillar network
organization. However, these observations apparently
contradict our results that the collagen content did not differ
between the three groups. One explanation for this inconsist-
ency could be differences between the reflex echoes from flat
ultrasound and focal ultrasound. Another explanation could be
differences in the ultrasonic frequency level (10 MHz vs 20 to
55 MHz). From an acoustic point of view, differences in the
surface reflection indicate significant alterations in the acous-
tic impedance among regenerated cartilage samples. There-
fore, the extracellular matrix, which includes not only collagen
but also proteoglycans and water in the intrafibrillar space and
molecular pore spaces of the extracellular matrix as hydrophilic
proteoglycan aggregates, should be related to the %MM. The
%MM reveals the microstructural changes in regenerated car-
tilage and can provide diagnostically important information
about the regenerated cartilage.
Two limitations of our study should be considered. First, the
maximum magnitude in our evaluation system could detect
microstructural changes in a layer to a depth of 500 µm [13].
Therefore, the maximum magnitude could only evaluate the
surface layer in human cartilage. However, it is of great signif-
icance to evaluate the surface layer of tissue-engineered carti-
lage, since this layer plays an important role in the
biomechanical function of the joint. Therefore, ultrasound rep-
resents a sensitive tool for detecting regeneration of the carti-
lage surface in tissue engineering. Further studies using low-
frequency ultrasound may provide a better assessment of the
deeper layers in tissue-engineered cartilage. Second, we did
not detect cartilage regeneration in living humans. However,
we have previously reported relevant clinical acoustic data
from human cartilage in situ under arthroscopy [7]. Therefore,
further studies are needed to determine whether this evalua-
tion system will prove beneficial for tissue-engineered carti-
lage using cell/scaffold complexes.
Conclusion
This study reports the first results regarding the relation
between quantitative ultrasound and the regeneration process
of tissue-engineered cartilage. Ultrasonic evaluation using a
wavelet map can support the evaluation of tissue-engineered
cartilage using cell/scaffold complexes. Ultrasonic assess-
ment using a wavelet map may contribute to the progress of
tissue engineering in the musculoskeletal field, and the %MM
obtained from this ultrasonic assessment can be expected to
become one of the quantitative indexes of cartilage regenera-
tion therapy.
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